108 related articles for article (PubMed ID: 23047570)
1. Equilibrium radionuclide ventriculography in the assessment of cardiotoxicity of chemotherapy and chemoradiotherapy in patients with breast cancer.
Lapińska G; Kozłowicz-Gudzińska I; Sackiewicz-Słaby A
Nucl Med Rev Cent East Eur; 2012 Apr; 15(1):26-30. PubMed ID: 23047570
[TBL] [Abstract][Full Text] [Related]
2. [Risk of cardiotoxicity of combination treatment radiotherapy and chemotherapy of locally advanced breast carcinoma stage III].
Bustová I
Klin Onkol; 2009; 22(1):17-21. PubMed ID: 19534435
[TBL] [Abstract][Full Text] [Related]
3. Baseline diastolic dysfunction as a predictive factor of trastuzumab-mediated cardiotoxicity after adjuvant anthracycline therapy in breast cancer.
Cochet A; Quilichini G; Dygai-Cochet I; Touzery C; Toubeau M; Berriolo-Riedinger A; Coudert B; Cottin Y; Fumoleau P; Brunotte F
Breast Cancer Res Treat; 2011 Dec; 130(3):845-54. PubMed ID: 21918836
[TBL] [Abstract][Full Text] [Related]
4. Assessment of early epirubicin cardiotoxicity in women with breast cancer.
Sobić-Saranović D; Pavlović S; Susnjar S; Neskovi c-Konstantinović Z; Jelić S
Anticancer Res; 1997; 17(5B):3889-91. PubMed ID: 9427798
[TBL] [Abstract][Full Text] [Related]
5. Comparison of epirubicin and doxorubicin cardiotoxicity induced by low doses: evolution of the diastolic and systolic parameters studied by radionuclide angiography.
Cottin Y; Touzery C; Dalloz F; Coudert B; Toubeau M; Riedinger A; Louis P; Wolf JE; Brunotte F
Clin Cardiol; 1998 Sep; 21(9):665-70. PubMed ID: 9755384
[TBL] [Abstract][Full Text] [Related]
6. Evaluation and management of chemotherapy-induced cardiotoxicity in breast cancer: a Delphi study.
Gavila J; Seguí MÁ; Calvo L; López T; Alonso JJ; Farto M; Sánchez-de la Rosa R
Clin Transl Oncol; 2017 Jan; 19(1):91-104. PubMed ID: 27101413
[TBL] [Abstract][Full Text] [Related]
7. Drug-induced cardiotoxicity studied by longitudinal B-type natriuretic peptide assays and radionuclide ventriculography.
Pichon MF; Cvitkovic F; Hacene K; Delaunay J; Lokiec F; Collignon MA; Pecking AP
In Vivo; 2005; 19(3):567-76. PubMed ID: 15875778
[TBL] [Abstract][Full Text] [Related]
8. Repetitive dobutamine stress echocardiography for the prediction of anthracycline cardiotoxicity.
Bountioukos M; Doorduijn JK; Roelandt JR; Vourvouri EC; Bax JJ; Schinkel AF; Kertai MD; Sonneveld P; Poldermans D
Eur J Echocardiogr; 2003 Dec; 4(4):300-5. PubMed ID: 14611826
[TBL] [Abstract][Full Text] [Related]
9. [The analysis of left ventricular filling dynamics by radionuclide ventriculography using ECG's R wave and the second heart sound gating techniques].
Ishida Y; Inoue M; Matsumoto M; Fukushima M; Kim BH; Yamamoto K; Tsuneoka Y; Hiraoka T; Kimura K; Abe H
J Cardiogr; 1984 Jun; 14(1):75-84. PubMed ID: 6520428
[TBL] [Abstract][Full Text] [Related]
10. Left ventricular systolic function in HER2/neu negative breast cancer patients treated with anthracycline chemotherapy: a comparative analysis of left ventricular ejection fraction and myocardial strain imaging over 12 months.
Stoodley PW; Richards DA; Boyd A; Hui R; Harnett PR; Meikle SR; Byth K; Stuart K; Clarke JL; Thomas L
Eur J Cancer; 2013 Nov; 49(16):3396-403. PubMed ID: 23937961
[TBL] [Abstract][Full Text] [Related]
11. Independent and incremental value of deformation indices for prediction of trastuzumab-induced cardiotoxicity.
Negishi K; Negishi T; Hare JL; Haluska BA; Plana JC; Marwick TH
J Am Soc Echocardiogr; 2013 May; 26(5):493-8. PubMed ID: 23562088
[TBL] [Abstract][Full Text] [Related]
12. Time Trends of Left Ventricular Ejection Fraction and Myocardial Deformation Indices in a Cohort of Women with Breast Cancer Treated with Anthracyclines, Taxanes, and Trastuzumab.
Tan TC; Bouras S; Sawaya H; Sebag IA; Cohen V; Picard MH; Passeri J; Kuter I; Scherrer-Crosbie M
J Am Soc Echocardiogr; 2015 May; 28(5):509-14. PubMed ID: 25772019
[TBL] [Abstract][Full Text] [Related]
13. Non-invasive monitoring of cardiac hemodynamic parameters in doxorubicin-treated patients: comparison with echocardiography.
Villani F; Meazza R; Materazzo C
Anticancer Res; 2006; 26(1B):797-801. PubMed ID: 16739356
[TBL] [Abstract][Full Text] [Related]
14. Does left ventricular diastolic function deteriorate earlier than left ventricular systolic function in anthracycline cardiotoxicity?
Patel CD; Balakrishnan VB; Kumar L; Naswa N; Malhotra A
Hell J Nucl Med; 2010; 13(3):233-7. PubMed ID: 21193876
[TBL] [Abstract][Full Text] [Related]
15. [Early detection of cardiotoxicity of anthracyclines. Value of isotopic method].
Massing JL; Caillot D; Mouhat T; Schlesser P; Solary E
Arch Mal Coeur Vaiss; 1996 Jan; 89(1):57-62. PubMed ID: 8678739
[TBL] [Abstract][Full Text] [Related]
16. Anticancer agents and cardiotoxicity.
Ng R; Better N; Green MD
Semin Oncol; 2006 Feb; 33(1):2-14. PubMed ID: 16473642
[TBL] [Abstract][Full Text] [Related]
17. Cardiotoxicity of anthracycline in young breast cancer female patients: the possibility of detection of early cardiotoxicity by TDI.
Nagy AC; Tolnay E; Nagykálnai T; Forster T
Neoplasma; 2006; 53(6):511-7. PubMed ID: 17167721
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of adriamycin cardiotoxicity using equilibrium radionuclide ventriculography. II. Results during exercise].
Knesewitsch P; Göldel NH; Fritsch S; Moser E
Nuklearmedizin; 1987 Oct; 26(5):212-9. PubMed ID: 3432065
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of left ventricular function in patients with mammary carcinoma after treatment with epidoxorubicin using a high-dose, short-term protocol].
D'Alto M; Maurea S; Basso A; Polverino W; Bianchi U; Bonelli A; Silvestro P; Salvatore M; Chiariello M
Cardiologia; 1997 Jun; 42(6):611-8. PubMed ID: 9289377
[TBL] [Abstract][Full Text] [Related]
20. Subclinical anthracycline- and trastuzumab-induced cardiotoxicity in the long-term follow-up of asymptomatic breast cancer survivors: a speckle tracking echocardiographic study.
Ho E; Brown A; Barrett P; Morgan RB; King G; Kennedy MJ; Murphy RT
Heart; 2010 May; 96(9):701-7. PubMed ID: 20424152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
